LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
10.19
-0.16 (-1.55%)
Nov 28, 2025, 1:00 PM EST - Market closed
LENSAR Market Cap
LENSAR has a market cap or net worth of $121.6 million as of November 28, 2025. Its market cap has increased by 48.71% in one year.
Market Cap
121.60M
Enterprise Value
107.61M
1-Year Change
48.71%
Ranking
Category
Stock Price
$10.19
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $121.60M, an increase of 55.88%. That is a compound annual growth rate of 8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 121.60M | 17.10% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |